Discontinuation report APO-SERTRALINE

Last updated on 2018-09-15 History
Report ID 60781
Drug Identification Number 02238282
Brand name APO-SERTRALINE
Common or Proper name SERTRALINE
Company Name APOTEX INC
Market Status MARKETED
Active Ingredient(s) SERTRALINE
Strength(s) 100MG
Dosage form(s) CAPSULE
Route of administration ORAL
Packaging size 250 BTL
ATC code N06AB
ATC description ANTIDEPRESSANTS
Reason for discontinuation Business reasons
Anticipated discontinuation date
Actual discontinuation date 2018-09-14
Remaining supply date 2018-09-14
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v3 2018-09-15 English Compare
v2 2018-09-08 French Compare
v1 2018-09-08 English Compare

Showing 1 to 3 of 3